TransMedics Group, Inc. Quarterly Debt-to-equity in % from Q3 2019 to Q4 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
TransMedics Group, Inc. quarterly Debt-to-equity history and growth rate from Q3 2019 to Q4 2024.
  • TransMedics Group, Inc. Debt-to-equity for the quarter ending December 31, 2024 was 290 %, a 1.55% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2024 290 -4.56 -1.55% Dec 31, 2024
Q3 2024 327 +129 +64.9% Sep 30, 2024
Q2 2024 369 +255 +223% Jun 30, 2024
Q1 2024 394 +340 +623% Mar 31, 2024
Q4 2023 294 +231 +366% Dec 31, 2023
Q3 2023 198 +121 +155% Sep 30, 2023
Q2 2023 114 +17.3 +17.8% Jun 30, 2023
Q1 2023 54.6 -25.1 -31.5% Mar 31, 2023
Q4 2022 63.2 -2.62 -3.98% Dec 31, 2022
Q3 2022 77.6 +23.3 +43% Sep 30, 2022
Q2 2022 97.2 +47.9 +96.9% Jun 30, 2022
Q1 2022 79.7 +33.7 +73.2% Mar 31, 2022
Q4 2021 65.8 +13 +24.6% Dec 31, 2021
Q3 2021 54.3 -7.33 -11.9% Sep 30, 2021
Q2 2021 49.4 -22.2 -31% Jun 30, 2021
Q1 2021 46 -38.7 -45.7% Mar 31, 2021
Q4 2020 52.8 +2.11K Dec 31, 2020
Q3 2020 61.6 +139 Sep 30, 2020
Q2 2020 71.6 Jun 30, 2020
Q1 2020 84.7 Mar 31, 2020
Q4 2019 -2.06K Dec 28, 2019
Q3 2019 -77.2 Sep 28, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.